Literature DB >> 16696662

The Skn7 response regulator of Cryptococcus neoformans is involved in oxidative stress signalling and augments intracellular survival in endothelium.

Frank E J Coenjaerts1, Andy I M Hoepelman, Jelle Scharringa, Marieke Aarts, Pauline M Ellerbroek, Lisette Bevaart, Jos A G Van Strijp, Guilhem Janbon.   

Abstract

Cryptococcus neoformans is the causative agent of cryptococcal meningoencephalitis. There is accumulating evidence that C. neoformans is a facultative intracellular pathogen, residing in macrophages and endothelium. The molecular mechanism conferring resistance to phagolysosomal killing in these cells is a key unresolved issue. To gain insight into the fungal adaptive strategies, serial analysis of gene expression was used to map genes differentially expressed in an intraphagocytic environment. By comparing transcript profiles of C. neoformans serotype D B3501 cells recovered from endothelial cells with those from free-grown cryptococci, we identified the cryptococcal homologue of the SKN7 two-component stress response regulator gene from Saccharomyces cerevisiae. Studies with C. neoformans cells disrupted for SKN7 revealed an increased susceptibility to t-butyl hydroperoxide (100% lethality at 0.7 mM, vs. 1.0 mM for wild type) and significantly lower survival rates in endothelial infection experiments. Mice experiments revealed that SKN7 disruption strongly attenuates cryptococcal virulence in vivo. We propose that Skn7 (co-)regulates the fungal adaptive strategy, allowing intraphagocytic survival by conferring resistance to phagolysosomal killing in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16696662     DOI: 10.1111/j.1567-1364.2006.00065.x

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  22 in total

1.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

Review 2.  Fungal Skn7 stress responses and their relationship to virulence.

Authors:  Jan S Fassler; Ann H West
Journal:  Eukaryot Cell       Date:  2010-12-03

Review 3.  Cryptococcus neoformans, a fungus under stress.

Authors:  Sarah M Brown; Leona T Campbell; Jennifer K Lodge
Journal:  Curr Opin Microbiol       Date:  2007-08-17       Impact factor: 7.934

Review 4.  Master and commander in fungal pathogens: the two-component system and the HOG signaling pathway.

Authors:  Yong-Sun Bahn
Journal:  Eukaryot Cell       Date:  2008-10-24

Review 5.  Two-component signal transduction proteins as potential drug targets in medically important fungi.

Authors:  Neeraj Chauhan; Richard Calderone
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

6.  A Zebrafish Model of Cryptococcal Infection Reveals Roles for Macrophages, Endothelial Cells, and Neutrophils in the Establishment and Control of Sustained Fungemia.

Authors:  J Muse Davis; Mingwei Huang; Michael R Botts; Christina M Hull; Anna Huttenlocher
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 7.  Current understanding of HOG-MAPK pathway in Aspergillus fumigatus.

Authors:  Dongmei Ma; Ruoyu Li
Journal:  Mycopathologia       Date:  2012-11-18       Impact factor: 2.574

Review 8.  Signalling pathways in the pathogenesis of Cryptococcus.

Authors:  Lukasz Kozubowski; Soo Chan Lee; Joseph Heitman
Journal:  Cell Microbiol       Date:  2008-12-19       Impact factor: 3.715

9.  Penicillium marneffei SKN7, a novel gene, could complement the hypersensitivity of S. cerevisiae skn7 Disruptant strain to oxidative stress.

Authors:  Cunwei Cao; Wei Liu; Ruoyu Li
Journal:  Mycopathologia       Date:  2009-03-18       Impact factor: 2.574

Review 10.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.